INVO Fertility, Inc.
For the period ended Dec 31, 2024. Filed Apr 30, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Apr 30, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 14. Principal Accountant Fees and Services
The following table represents aggregate fees billed to the Company by M&K.
| Fiscal Year Ended December 31, 2023 · Fiscal Year Ended December 31, 2022 | ||||
|---|---|---|---|---|
| Audit Fees | $71,350 | $61,740 | ||
| Audit Related Fees | $44,350 | $53,250 | ||
| Tax Fees | $ | - | $ | - |
| All Other Fees | $ | - | $ | - |
Audit Fees includes fees billed for the fiscal year shown for professional services for the audit of the Company’s annual financial statements, the reviews of the consolidated quarterly financial statements included in each of our quarterly reports on Form 10-Q, and other audit services.
Audit-Related Fees include fees for assurance and related services performed to comply with generally accepted auditing standards and including audit of target acquisition companies and comfort and consent letters in connection with SEC filings and financing transactions.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.